Congress – Page 11 – Policy & Medicine

Grassley Expresses Concern Over DOJ Dismissal of FCA Cases

Pelosi Draft Plan Would Allow Price Negotiations on Select Drugs

Concerns About Unintended Consequences of Drug Pricing Transparency Bills

Senators Grassley and Wyden Expand Their Opioid Investigation to Tax-Exempt Organizations

Senate Health Subcommittee Releases Discussion Draft of Legislation to Lower Healthcare Costs

Biopharma Executives Answer Senate Finance Committee Questions on Policies to Increase Biosimilar Use

House E&C Panel Republicans Push Back on Drug Transparency Bills

MedPAC Provides Congress Policy Options to Reigning-In Specialty Drug Spending

Senate Finance Committee Reviews MACRA Implementation and Solicits Recommendations for Improvement

Bipartisanship Returns to Congress?